Gordon Cameron
Direttore Finanziario/CFO presso Quotient Sciences Ltd.
Patrimonio netto: 50 962 $ in data 30/04/2024
Profilo
Gordon Cameron currently works at Quotient Sciences Ltd., as Chief Financial Officer & Director from 2007, Quotient Sciences (Reading) Ltd., as Chief Financial Officer & Director from 2013, and Quad UK Topco Ltd., as Secretary & Director.
Mr. Cameron also formerly worked at Acambis Plc, as Chief Executive Officer and Quotient Bioscience Ltd., as Chief Financial Officer.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/08/2023 | 74 000 ( 0.02% ) | 50 962 $ | 30/04/2024 |
Posizioni attive di Gordon Cameron
Società | Posizione | Inizio |
---|---|---|
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom. | Direttore Finanziario/CFO | 01/01/2007 |
Quotient Sciences (Reading) Ltd.
Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Direttore Finanziario/CFO | 01/01/2013 |
Quad UK Topco Ltd.
Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2019, Quad UK Topco Ltd. is a holding company that oversees subsidiaries engaged in pharmaceutical research, development, and manufacturing. The company is based in Ruddington, UK. | Direttore/Membro del Consiglio | 01/10/2019 |
Precedenti posizioni note di Gordon Cameron
Società | Posizione | Fine |
---|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Presidente | 09/03/2007 |
Quotient Bioscience Ltd.
Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Quotient Bioscience Ltd. offers drug development services. It provides services on a standalone basis, or integrated, to deliver customers bespoke development programs. The company was founded in 2007 and is headquartered in Ely, the united Kingdom. | Direttore Finanziario/CFO | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Quotient Bioscience Ltd.
Quotient Bioscience Ltd. Miscellaneous Commercial ServicesCommercial Services Quotient Bioscience Ltd. offers drug development services. It provides services on a standalone basis, or integrated, to deliver customers bespoke development programs. The company was founded in 2007 and is headquartered in Ely, the united Kingdom. | Commercial Services |
Quotient Sciences (Reading) Ltd.
Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Health Technology |
Quad UK Topco Ltd.
Quad UK Topco Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2019, Quad UK Topco Ltd. is a holding company that oversees subsidiaries engaged in pharmaceutical research, development, and manufacturing. The company is based in Ruddington, UK. | Health Technology |
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Gordon Cameron